Skip to content


  • Invited speaker presentation
  • Open Access

IL-12 superfamily members guiding the function of Rorγt-dependent innate lymphocytes

  • 1
Journal of Translational Medicine201210 (Suppl 3) :I15

  • Published:


  • Cellular Immune Response
  • Intracellular Pathogen
  • Skin Tumor
  • Innate Response
  • Superfamily Member

Most MHC class II expressing Ag-presenting cells (APCs) have the capacity to produce the cytokines IL-12 and IL-23 [1]. Both these heterodimeric pro-inflammatory cytokines share a common subunit (p40) which is covalently linked to p35 to form IL-12 and to p19 to form IL-23. The biology of these two related cytokines is extremely divers. IL-12 is best known for its capacity to polarize TH1 cells and to activate NK and NKT cells. IL-12 is thus primarily involved in the initiation of cellular immune responses agains intracellular pathogens. The biology of IL-23 is much less understood, but it becomes increasingly clear that IL-23 can activate innate lymphocytes including a subclass of γδ T cells [2] and Rorγt-dependent innate lymphocytes (ILCs) [3]. IL-23 is further critical for the development of self-reactive pathogenic αβ helper T cells in various models of autoimmune diseases [4].

In the context of anti-tumor immunity we discovered that IL-23 plays only a minor role in the development of anti-tumor responses. In fact, we found IL-23 to have primarily tumor-supportive properties. In contrast, IL-12 has clearly a potent tumor-suppressive properties. Surprisingly, we identified a Rorγt-dependent IL-12R bearing ILC homing into the microenvironment of skin tumors [5]. These ILCs upon sensing IL-12 are able to mount a potent innate response in the tumor-microenvironment, leading to alterations in tumor microvessels and the formation of a pro-inflammatory myeloid cell response. Taken together, our initial understanding of IL-12 and IL-23 biology was restricted to adaptive T cells. The impact of these cytokines on γδ T cells and ILCs is only now being discovered.

Authors’ Affiliations

Institute of Experimental Immunology, University of Zurich, Switzerland


  1. Gutcher I, Becher B: APC-derived cytokines and T cell polarization in autoimmune inflammation. J.Cin. Invest. 2007, 117: 1119-1127. 10.1172/JCI31720.View ArticleGoogle Scholar
  2. Pantelyushin S, Haak S, Ingold B, Kulig P, Heppner FL, Navarini AA, Becher B: Rorgammat+ innate lymphocytes and gammadelta T cells initiate psoriasiform plaque formation in mice. J.Cin. Invest. 2012, 122: 2252-2256. 10.1172/JCI61862.View ArticleGoogle Scholar
  3. Vonarbourg C, Mortha A, Bui VL, Hernandez PP, Kiss EA, Hoyler T, Flach M: Regulated expression of nuclear receptor RORγt confers distinct functional fates to NK cell receptor-expressing RORγt(+) innate lymphocytes. Immunity. 2010, 33: 736-751. 10.1016/j.immuni.2010.10.017.PubMed CentralView ArticlePubMedGoogle Scholar
  4. Croxford AL, Mair F, Becher B: IL-23: One cytokine in control of autoimmunity. Eur. J. Immunol. 2012, 42: 2263-2273. 10.1002/eji.201242598.View ArticlePubMedGoogle Scholar
  5. Eisenring M, vom Berg J, Kristiansen G, Saller E, Becher B: IL-12 initiates tumor rejection via lymphoid tissue-inducer cells bearing the natural cytotoxicity receptor NKp46. Nat Immunol. 2010, 11: 1030-1038. 10.1038/ni.1947.View ArticlePubMedGoogle Scholar